De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Gufic Biosciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Gufic Biosciences heeft een totaal eigen vermogen van ₹5.3B en een totale schuld van ₹3.3B, wat de schuld-eigenvermogensverhouding op 62.5% brengt. De totale activa en totale passiva bedragen respectievelijk ₹10.9B en ₹5.6B. De EBIT Gufic Biosciences is ₹1.3B waardoor de rentedekking 8.1 is. Het heeft contanten en kortetermijnbeleggingen van ₹134.8M.
Belangrijke informatie
62.5%
Verhouding schuld/eigen vermogen
₹3.33b
Schuld
| Rente dekkingsratio | 8.1x |
| Contant | ₹134.84m |
| Aandelen | ₹5.33b |
| Totaal verplichtingen | ₹5.60b |
| Totaal activa | ₹10.93b |
Recente financiële gezondheidsupdates
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹6.0B ) GUFICBIO } overtreffen de korte termijn passiva ( ₹3.7B ).
Langlopende schulden: De kortetermijnactiva GUFICBIO ( ₹6.0B ) overtreffen de langetermijnschulden ( ₹1.9B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 60% ) GUFICBIO wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van GUFICBIO is de afgelopen 5 jaar gedaald van 127.4% naar 62.5%.
Schuldendekking: De operationele kasstroom van GUFICBIO is negatief, waardoor de schuld niet goed gedekt is.
Rentedekking: De rentebetalingen op de schuld van GUFICBIO worden goed gedekt door EBIT ( 8.1 x dekking).